Tumor‐targeting Salmonella typhimurium A1‐R arrests a doxorubicin‐resistant PDGFRA‐amplified patient‐derived orthotopic xenograft mouse model of pleomorphic liposarcoma. Issue 9 (22nd June 2018)
- Record Type:
- Journal Article
- Title:
- Tumor‐targeting Salmonella typhimurium A1‐R arrests a doxorubicin‐resistant PDGFRA‐amplified patient‐derived orthotopic xenograft mouse model of pleomorphic liposarcoma. Issue 9 (22nd June 2018)
- Main Title:
- Tumor‐targeting Salmonella typhimurium A1‐R arrests a doxorubicin‐resistant PDGFRA‐amplified patient‐derived orthotopic xenograft mouse model of pleomorphic liposarcoma
- Authors:
- Kiyuna, Tasuku
Tome, Yasunori
Murakami, Takashi
Zhao, Ming
Miyake, Kentaro
Igarashi, Kentaro
Kawaguchi, Kei
Miyake, Masuyo
Oshiro, Hiromichi
Higuchi, Takashi
Li, Yunfeng
Dry, Sarah M.
Nelson, Scott D.
Russell, Tara A.
Eckardt, Mark A.
Singh, Arun S.
Kanaya, Fuminori
Eilber, Fritz C.
Hoffman, Robert M. - Abstract:
- Abstract: Pleomorphic liposarcoma (PLPS) is a recalcitrant soft‐tissue sarcoma (STS) subtype in need of transformative therapy. We have previously established a patient‐derived orthotopic xenograft (PDOX) model, of PLPS with PDGFRA amplification, using surgical orthotopic implantation. In the current study, the PLPS PDOX model was randomized into 3 groups of 7 mice each: untreated control; doxorubicin (DOX)‐treated; and treated with Salmonella typhimurium A1‐R ( S. typhimurium A1‐R) expressing green fluorescent protein (GFP). Tumor volume and body weight were monitored during the treatment period. The PLPS PDOX was resistant to DOX. In contrast, the PLPS PDOX was highly sensitive to S. typhimurium A1‐R. There was no significant body‐weight loss among these 3 groups. Fluorescence imaging demonstrated that S. typhimurium A1‐R‐GFP was very effective to target the PLPS PDOX tumor. The current study demonstrates that a PLPS PDOX, resistant to first‐line therapy DOX, was highly sensitive to tumor targeting S. typhimurium A1‐R. Abstract : Tumor‐targeting Salmonella typhimurium A1‐R‐GFP of the PLPS PDOX. S. typhimurium, expressing green fluorescent protein (GFP), was cultivated in serial dilution from supernatants of tumor homogenates by mincing tumor tissue on agar medium. Grown colonies of bacterial were imaged by GFP fluorescence. Fluorescent bacteria were detected at all dilutions in the tumor treated with S. typhimurium A1‐R. Scale bar: 10 mm, 2.5 mm at high magnification. BF:Abstract: Pleomorphic liposarcoma (PLPS) is a recalcitrant soft‐tissue sarcoma (STS) subtype in need of transformative therapy. We have previously established a patient‐derived orthotopic xenograft (PDOX) model, of PLPS with PDGFRA amplification, using surgical orthotopic implantation. In the current study, the PLPS PDOX model was randomized into 3 groups of 7 mice each: untreated control; doxorubicin (DOX)‐treated; and treated with Salmonella typhimurium A1‐R ( S. typhimurium A1‐R) expressing green fluorescent protein (GFP). Tumor volume and body weight were monitored during the treatment period. The PLPS PDOX was resistant to DOX. In contrast, the PLPS PDOX was highly sensitive to S. typhimurium A1‐R. There was no significant body‐weight loss among these 3 groups. Fluorescence imaging demonstrated that S. typhimurium A1‐R‐GFP was very effective to target the PLPS PDOX tumor. The current study demonstrates that a PLPS PDOX, resistant to first‐line therapy DOX, was highly sensitive to tumor targeting S. typhimurium A1‐R. Abstract : Tumor‐targeting Salmonella typhimurium A1‐R‐GFP of the PLPS PDOX. S. typhimurium, expressing green fluorescent protein (GFP), was cultivated in serial dilution from supernatants of tumor homogenates by mincing tumor tissue on agar medium. Grown colonies of bacterial were imaged by GFP fluorescence. Fluorescent bacteria were detected at all dilutions in the tumor treated with S. typhimurium A1‐R. Scale bar: 10 mm, 2.5 mm at high magnification. BF: Bright field, GFP: Green fluorescent protein. … (more)
- Is Part Of:
- Journal of cellular biochemistry. Volume 119:Issue 9(2018)
- Journal:
- Journal of cellular biochemistry
- Issue:
- Volume 119:Issue 9(2018)
- Issue Display:
- Volume 119, Issue 9 (2018)
- Year:
- 2018
- Volume:
- 119
- Issue:
- 9
- Issue Sort Value:
- 2018-0119-0009-0000
- Page Start:
- 7827
- Page End:
- 7833
- Publication Date:
- 2018-06-22
- Subjects:
- green fluorescent protein -- patient‐derived orthotopic xenograft -- PDGFRA amplification -- pleomorphic liposarcoma -- Salmonella typhimurium A1‐R -- soft‐tissue sarcoma -- tumor targeting
Cytochemistry -- Periodicals
572 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-4644 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/jcb.27183 ↗
- Languages:
- English
- ISSNs:
- 0730-2312
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4955.010000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24395.xml